Board of Directors

DR. NARUHITO HIGO
Board Chairman
Global Technology Development Officer
and Head of Quality Assurance
Hisamitsu
Pharmaceutical Co., Inc.

TAKESHI MASUMOTO
Vice Chairman
Chief Executive Officer
Noven Pharmaceuticals, Inc.
Noven Officers


John Choi is Noven’s Chief Administrative Officer and Chief Financial Officer. Mr. Choi, who joined Noven in 2010, most recently served Noven as its Executive Director – Business Planning & Analysis. Prior to Noven, Mr. Choi served as Director of Commercial Operations & Planning for Ther-Rx (a branded pharmaceutical division of KV Pharmaceuticals). Previously, he served Abbott Laboratories in various positions in the manufacturing operations, cost accounting, finance, and international divisions, and served as an expatriate at Abbott’s Korean affiliate, where he held leadership roles in financial planning and analysis and other commercial leadership roles.

Takehito Kiuchi is Noven’s Vice President, Hisamitsu Group Strategy & Planning. He joined Noven in March 2021. He has over 24 years’ experience in the pharmaceutical industry. Previously, he served Hisamitsu Pharmaceutical Co., Inc. in various positions in Business Development, Licensing, and Clinical Development, in both Japan and the US. He earned a Masters in Pharmaceutical Sciences from Showa University and holds a pharmacist license in Japan.